Mapping interaction sites on human chemokine receptors by deep mutational scanning

Jeremiah D. Heredia, Jihye Park, Riley J. Brubaker, Steven K. Szymanski, Kevin S. Gill, Erik Procko

Research output: Contribution to journalArticle

Abstract

Chemokine receptors CXCR4 and CCR5 regulate WBC trafficking and are engaged by the HIV-1 envelope glycoprotein gp120 during infection. We combine a selection of human CXCR4 and CCR5 libraries comprising nearly all of ∼7000 single amino acid substitutions with deep sequencing to define sequence-activity landscapes for surface expression and ligand interactions. After consideration of sequence constraints for surface expression, known interaction sites with HIV-1–blocking Abs were appropriately identified as conserved residues following library sorting for Ab binding, validating the use of deep mutational scanning to map functional interaction sites in G protein–coupled receptors. Chemokine CXCL12 was found to interact with residues extending asymmetrically into the CXCR4 ligand-binding cavity, similar to the binding surface of CXCR4 recognized by an antagonistic viral chemokine previously observed crystallographically. CXCR4 mutations distal from the chemokine binding site were identified that enhance chemokine recognition. This included disruptive mutations in the G protein–coupling site that diminished calcium mobilization, as well as conservative mutations to a membrane-exposed site (CXCR4 residues H79 2.45 and W161 4.50 ) that increased ligand binding without loss of signaling. Compared with CXCR4–CXCL12 interactions, CCR5 residues conserved for gp120 (HIV-1 BaL strain) interactions map to a more expansive surface, mimicking how the cognate chemokine CCL5 makes contacts across the entire CCR5 binding cavity. Acidic substitutions in the CCR5 N terminus and extracellular loops enhanced gp120 binding. This study demonstrates how comprehensive mutational scanning can define functional interaction sites on receptors, and novel mutations that enhance receptor activities can be found simultaneously. The Journal of Immunology, 2018, 200: 3825–3839.

Original languageEnglish (US)
Pages (from-to)3825-3839
Number of pages15
JournalJournal of Immunology
Volume200
Issue number11
DOIs
StatePublished - Jun 1 2018

Fingerprint

Chemokine Receptors
Chemokines
HIV Envelope Protein gp120
Mutation
Ligands
Libraries
HIV-1
Chemokine CXCL12
High-Throughput Nucleotide Sequencing
Chemokine CCL5
Amino Acid Substitution
Allergy and Immunology
Binding Sites
HIV
Calcium
Membranes
Infection

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Cite this

Heredia, J. D., Park, J., Brubaker, R. J., Szymanski, S. K., Gill, K. S., & Procko, E. (2018). Mapping interaction sites on human chemokine receptors by deep mutational scanning. Journal of Immunology, 200(11), 3825-3839. https://doi.org/10.4049/jimmunol.1800343

Mapping interaction sites on human chemokine receptors by deep mutational scanning. / Heredia, Jeremiah D.; Park, Jihye; Brubaker, Riley J.; Szymanski, Steven K.; Gill, Kevin S.; Procko, Erik.

In: Journal of Immunology, Vol. 200, No. 11, 01.06.2018, p. 3825-3839.

Research output: Contribution to journalArticle

Heredia, JD, Park, J, Brubaker, RJ, Szymanski, SK, Gill, KS & Procko, E 2018, 'Mapping interaction sites on human chemokine receptors by deep mutational scanning', Journal of Immunology, vol. 200, no. 11, pp. 3825-3839. https://doi.org/10.4049/jimmunol.1800343
Heredia, Jeremiah D. ; Park, Jihye ; Brubaker, Riley J. ; Szymanski, Steven K. ; Gill, Kevin S. ; Procko, Erik. / Mapping interaction sites on human chemokine receptors by deep mutational scanning. In: Journal of Immunology. 2018 ; Vol. 200, No. 11. pp. 3825-3839.
@article{31bb9d46a97945bf848114efff3c3653,
title = "Mapping interaction sites on human chemokine receptors by deep mutational scanning",
abstract = "Chemokine receptors CXCR4 and CCR5 regulate WBC trafficking and are engaged by the HIV-1 envelope glycoprotein gp120 during infection. We combine a selection of human CXCR4 and CCR5 libraries comprising nearly all of ∼7000 single amino acid substitutions with deep sequencing to define sequence-activity landscapes for surface expression and ligand interactions. After consideration of sequence constraints for surface expression, known interaction sites with HIV-1–blocking Abs were appropriately identified as conserved residues following library sorting for Ab binding, validating the use of deep mutational scanning to map functional interaction sites in G protein–coupled receptors. Chemokine CXCL12 was found to interact with residues extending asymmetrically into the CXCR4 ligand-binding cavity, similar to the binding surface of CXCR4 recognized by an antagonistic viral chemokine previously observed crystallographically. CXCR4 mutations distal from the chemokine binding site were identified that enhance chemokine recognition. This included disruptive mutations in the G protein–coupling site that diminished calcium mobilization, as well as conservative mutations to a membrane-exposed site (CXCR4 residues H79 2.45 and W161 4.50 ) that increased ligand binding without loss of signaling. Compared with CXCR4–CXCL12 interactions, CCR5 residues conserved for gp120 (HIV-1 BaL strain) interactions map to a more expansive surface, mimicking how the cognate chemokine CCL5 makes contacts across the entire CCR5 binding cavity. Acidic substitutions in the CCR5 N terminus and extracellular loops enhanced gp120 binding. This study demonstrates how comprehensive mutational scanning can define functional interaction sites on receptors, and novel mutations that enhance receptor activities can be found simultaneously. The Journal of Immunology, 2018, 200: 3825–3839.",
author = "Heredia, {Jeremiah D.} and Jihye Park and Brubaker, {Riley J.} and Szymanski, {Steven K.} and Gill, {Kevin S.} and Erik Procko",
year = "2018",
month = "6",
day = "1",
doi = "10.4049/jimmunol.1800343",
language = "English (US)",
volume = "200",
pages = "3825--3839",
journal = "Journal of Immunology",
issn = "0022-1767",
publisher = "American Association of Immunologists",
number = "11",

}

TY - JOUR

T1 - Mapping interaction sites on human chemokine receptors by deep mutational scanning

AU - Heredia, Jeremiah D.

AU - Park, Jihye

AU - Brubaker, Riley J.

AU - Szymanski, Steven K.

AU - Gill, Kevin S.

AU - Procko, Erik

PY - 2018/6/1

Y1 - 2018/6/1

N2 - Chemokine receptors CXCR4 and CCR5 regulate WBC trafficking and are engaged by the HIV-1 envelope glycoprotein gp120 during infection. We combine a selection of human CXCR4 and CCR5 libraries comprising nearly all of ∼7000 single amino acid substitutions with deep sequencing to define sequence-activity landscapes for surface expression and ligand interactions. After consideration of sequence constraints for surface expression, known interaction sites with HIV-1–blocking Abs were appropriately identified as conserved residues following library sorting for Ab binding, validating the use of deep mutational scanning to map functional interaction sites in G protein–coupled receptors. Chemokine CXCL12 was found to interact with residues extending asymmetrically into the CXCR4 ligand-binding cavity, similar to the binding surface of CXCR4 recognized by an antagonistic viral chemokine previously observed crystallographically. CXCR4 mutations distal from the chemokine binding site were identified that enhance chemokine recognition. This included disruptive mutations in the G protein–coupling site that diminished calcium mobilization, as well as conservative mutations to a membrane-exposed site (CXCR4 residues H79 2.45 and W161 4.50 ) that increased ligand binding without loss of signaling. Compared with CXCR4–CXCL12 interactions, CCR5 residues conserved for gp120 (HIV-1 BaL strain) interactions map to a more expansive surface, mimicking how the cognate chemokine CCL5 makes contacts across the entire CCR5 binding cavity. Acidic substitutions in the CCR5 N terminus and extracellular loops enhanced gp120 binding. This study demonstrates how comprehensive mutational scanning can define functional interaction sites on receptors, and novel mutations that enhance receptor activities can be found simultaneously. The Journal of Immunology, 2018, 200: 3825–3839.

AB - Chemokine receptors CXCR4 and CCR5 regulate WBC trafficking and are engaged by the HIV-1 envelope glycoprotein gp120 during infection. We combine a selection of human CXCR4 and CCR5 libraries comprising nearly all of ∼7000 single amino acid substitutions with deep sequencing to define sequence-activity landscapes for surface expression and ligand interactions. After consideration of sequence constraints for surface expression, known interaction sites with HIV-1–blocking Abs were appropriately identified as conserved residues following library sorting for Ab binding, validating the use of deep mutational scanning to map functional interaction sites in G protein–coupled receptors. Chemokine CXCL12 was found to interact with residues extending asymmetrically into the CXCR4 ligand-binding cavity, similar to the binding surface of CXCR4 recognized by an antagonistic viral chemokine previously observed crystallographically. CXCR4 mutations distal from the chemokine binding site were identified that enhance chemokine recognition. This included disruptive mutations in the G protein–coupling site that diminished calcium mobilization, as well as conservative mutations to a membrane-exposed site (CXCR4 residues H79 2.45 and W161 4.50 ) that increased ligand binding without loss of signaling. Compared with CXCR4–CXCL12 interactions, CCR5 residues conserved for gp120 (HIV-1 BaL strain) interactions map to a more expansive surface, mimicking how the cognate chemokine CCL5 makes contacts across the entire CCR5 binding cavity. Acidic substitutions in the CCR5 N terminus and extracellular loops enhanced gp120 binding. This study demonstrates how comprehensive mutational scanning can define functional interaction sites on receptors, and novel mutations that enhance receptor activities can be found simultaneously. The Journal of Immunology, 2018, 200: 3825–3839.

UR - http://www.scopus.com/inward/record.url?scp=85047962731&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85047962731&partnerID=8YFLogxK

U2 - 10.4049/jimmunol.1800343

DO - 10.4049/jimmunol.1800343

M3 - Article

C2 - 29678950

AN - SCOPUS:85047962731

VL - 200

SP - 3825

EP - 3839

JO - Journal of Immunology

JF - Journal of Immunology

SN - 0022-1767

IS - 11

ER -